Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Ferroni

Showing results (31-40 of 124) with videos related to

Pageof 13
Sort By:
Thrombosis and Haemostasis|April 2, 1999
Is soluble P-selectin determination a more reliable marker of in vivo platelet activation than CD62P flow cytometric analysis?P Ferroni, F M Pulcinelli, L Lenti, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|March 1, 1976
[Clinical control, study of viral shedding and evaluation of circulating and local antibody response after administration of live and attenuated "Alice" strain influenza vaccine]F Bergamini, M L Profeta, P Ferroni, et al.
Current Medicinal Chemistry|August 19, 2007
Contribution of platelet-derived CD40 ligand to inflammation, thrombosis and neoangiogenesisP Ferroni, F Santilli, F Guadagni, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
In vivo platelet activation is associated with increased plasma levels of vascular endothelial growth factorF Martini, S Riondino, S Basili, et al.
European Journal of Epidemiology|October 1, 1994
Hepatitis C viraemia and antibody to core epitopes in anti-HCV ELISA negative blood donorsP Ferroni, V Gasparini, M Zaninetti, et al.
Molecular Biotechnology|June 1, 1995
Detection and identification of Campylobacter coli and Campylobacter jejuni by two-step polymerase chain reactionG Comi, P Ferroni, L Cocolin, et al.
Rivista Di Emoterapia Ed Immunoematologia|January 1, 1986
[Acquired immunodeficiency syndrome (AIDS): present and future]A R Zanetti, E Tanzi, G Zehender, et al.
Lancet (London, England)|July 6, 1985
HTLV-III antibody among Italian drug addictsP Ferroni, D Geroldi, C Galli, et al.
Cancer Research|February 1, 1994
Evaluation of the potential role of class II histocompatibility antigen HLA-DR in platelet/tumor cell interactionP Ferroni, F Guadagni, A Spila, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
In vivo and in vitro clinical applications of monoclonal antibodies against TAG-72D Colcher, D E Milenic, P Ferroni, et al.
Pageof 13

Showing results (31-40 of 124) with videos related to

Sort By:
Pageof 13
Thrombosis and Haemostasis|April 2, 1999
Is soluble P-selectin determination a more reliable marker of in vivo platelet activation than CD62P flow cytometric analysis?P Ferroni, F M Pulcinelli, L Lenti, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|March 1, 1976
[Clinical control, study of viral shedding and evaluation of circulating and local antibody response after administration of live and attenuated "Alice" strain influenza vaccine]F Bergamini, M L Profeta, P Ferroni, et al.
Current Medicinal Chemistry|August 19, 2007
Contribution of platelet-derived CD40 ligand to inflammation, thrombosis and neoangiogenesisP Ferroni, F Santilli, F Guadagni, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
In vivo platelet activation is associated with increased plasma levels of vascular endothelial growth factorF Martini, S Riondino, S Basili, et al.
European Journal of Epidemiology|October 1, 1994
Hepatitis C viraemia and antibody to core epitopes in anti-HCV ELISA negative blood donorsP Ferroni, V Gasparini, M Zaninetti, et al.
Molecular Biotechnology|June 1, 1995
Detection and identification of Campylobacter coli and Campylobacter jejuni by two-step polymerase chain reactionG Comi, P Ferroni, L Cocolin, et al.
Rivista Di Emoterapia Ed Immunoematologia|January 1, 1986
[Acquired immunodeficiency syndrome (AIDS): present and future]A R Zanetti, E Tanzi, G Zehender, et al.
Lancet (London, England)|July 6, 1985
HTLV-III antibody among Italian drug addictsP Ferroni, D Geroldi, C Galli, et al.
Cancer Research|February 1, 1994
Evaluation of the potential role of class II histocompatibility antigen HLA-DR in platelet/tumor cell interactionP Ferroni, F Guadagni, A Spila, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
In vivo and in vitro clinical applications of monoclonal antibodies against TAG-72D Colcher, D E Milenic, P Ferroni, et al.
Pageof 13